Lesion Volume Dynamics Add Prognostic Value Beyond Prostate Imaging Reporting and Data System Score Increase for Predicting Confirmatory Biopsy Upgrade During Active Surveillance
Journal of Urologic Oncology · 31.07.2026 · 24 (2) · 127-136
DOI: 10.22465/juo.265200080004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Urologic Oncology, erschienen am 31.07.2026. Verfasst von Theodoros Karanikolas und 7 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Purpose
This study aimed to evaluate the association of Prostate Imaging Reporting and Data System (PIRADS) score increase and lesion volume progression on serial prostate magnetic resonance imaging (MRI) with confirmatory biopsy outcomes in a racially and ethnically diverse cohort of patients undergoing active surveillance for prostate cancer.Materials and Methods: We conducted a single-center retrospective cohort study of men with Gleason 3+3 and 3+4 prostate cancer managed with active surveillance at our institution from 2016 to 2025 who had diagnostic and confirmatory biopsies and corresponding prostate MRI examinations within prespecified windows of each biopsy. Biopsy-level, demographic, clinical, imaging, and treatment data were abstracted. Imaging progression was defined as any increase in maximum PI-RADS score or a ≥30% increase in maximum lesion volume (MLV). Outcomes included Gleason grade group (GG) upgrading and increased length of Gleason pattern 4 (GP4) on confirmatory biopsy. Multivariable logistic regression models adjusted for age, race/ethnicity, time between biopsies, prostate-specific antigen density, and GG at diagnosis were used to evaluate associations between imaging progression and upgrading. Receiver operating characteristic analysis was used to compare discriminative performance.
Results
Among 160 patients (73% Black or Hispanic/Latino), 52 (32.5%) had upgrading at confirmatory biopsy. In separate multivariable models, both PI-RADS score increase (odds ratio [OR], 4.06; 95% confidence interval [CI], 1.77–9.76; p=0.001) and MLV increase ≥30% (OR, 4.29; 95% CI, 1.98–9.74; p
Zitieren
APA
Karanikolas, T., Tripp, J., Joseph, M., Li, A., Agalliu, I., Reese, S., Kanmaniraja, D., & Watts, K. (2026). Lesion Volume Dynamics Add Prognostic Value Beyond Prostate Imaging Reporting and Data System Score Increase for Predicting Confirmatory Biopsy Upgrade During Active Surveillance. Journal of Urologic Oncology, 24(2), 127-136. https://doi.org/10.22465/juo.265200080004
Vancouver
Karanikolas T, Tripp J, Joseph M, Li A, Agalliu I, Reese S, et al. Lesion Volume Dynamics Add Prognostic Value Beyond Prostate Imaging Reporting and Data System Score Increase for Predicting Confirmatory Biopsy Upgrade During Active Surveillance. Journal of Urologic Oncology. 2026;24(2):127-136. doi:10.22465/juo.265200080004
BibTeX
@article{Karanikolas2026,
author = {Karanikolas, Theodoros and Tripp, Jonah and Joseph, Morgan and Li, Arleen and Agalliu, Ilir and Reese, Stephen and Kanmaniraja, Devaraju and Watts, Kara},
title = {Lesion Volume Dynamics Add Prognostic Value Beyond Prostate Imaging Reporting and Data System Score Increase for Predicting Confirmatory Biopsy Upgrade During Active Surveillance},
journal = {Journal of Urologic Oncology},
year = {2026},
volume = {24},
number = {2},
pages = {127--136},
doi = {10.22465/juo.265200080004}
}
EUVIMED